FDA NDC Directory · JSON-LD · Markdown

Vyndaqel

NDC 0069-1975 · HUMAN PRESCRIPTION DRUG · CAPSULE, LIQUID FILLED

Generic nametafamidis meglumine
Labeler / ManufacturerPfizer Laboratories Div Pfizer Inc
Marketing categoryNew Drug Application (innovator) · App NDA211996
Dosage form / routeCAPSULE, LIQUID FILLED · ORAL
Active ingredientsTAFAMIDIS MEGLUMINE (20 mg/1)
Marketing started20190516
Marketing ended20270731
Package count1

External sources

Source: openFDA. Public-domain (CC0).